Nanosphere to Release Preliminary Fourth Quarter & Fiscal Year 2014 Results and Host Investor Conference Call on Wednesday, January 28

NORTHBROOK, Ill., Jan. 26, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report preliminary results for the fourth quarter and fiscal year ended December 31, 2014, as well as a business update after the market close on Wednesday, January 28, 2015. The company will also hold a live investor conference call and webcast at 5:00pm Eastern/2:00pm Pacific.

Conference Call & Webcast
Wednesday, January 28, 2015 @ 5:00pm Eastern Time/2:00pm Pacific Time

Domestic: 888-430-8709
International: 719-325-2484
Passcode: 8778910
Replays – Available through February 11, 2015
Domestic:  877-870-5176
International:  858-384-5517
Passcode:  8778910

About Nanosphere, Inc.

Nanosphere is enhancing medicine through targeted molecular diagnostics that result in earlier disease detection, optimal patient treatment and improved healthcare economics. The Company's versatile technology platform, the Verigene® System, enables clinicians to rapidly detect the most complex, costly and deadly infectious diseases through a low cost and simple-to-use multiplexed diagnostic test. The combination of this innovative technology and Nanosphere's customer-driven solutions keeps commitment to the patient at the forefront of its business. Nanosphere is based in Northbrook, IL. Additional information is available at

Except for historical information, the matters discussed in this press release are "forward-looking statements" and are subject to risks and uncertainties. Actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the following: (i) Nanosphere's ability to develop commercially viable products; (ii) Nanosphere's ability to achieve profitability; (iii) Nanosphere's ability to produce and market its products; (iv) Nanosphere's ability to obtain regulatory approval of its products; (v) Nanosphere's ability to protect its intellectual property; (vi) competition and alternative technologies; and (vii) Nanosphere's ability to obtain additional financing to support its operations. Additional risks are discussed in the Company's current filings with the Securities and Exchange Commission. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. The forward-looking statements are made as of the date of this press release, and we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

CONTACT: Investors:
         Roger Moody
         Chief Financial Officer
         Nanosphere, Inc.
         Michael Rice
         Founding Partner
         LifeSci Advisors
         Rebecca Schechner
         Nanosphere, Inc.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.